Free Trial

Sareum (SAR) Competitors

Sareum logo
GBX 14.50 -2.00 (-12.12%)
As of 10:35 AM Eastern

SAR vs. PHD, FEN, NMT, IGR, GLV, TSI, CGO, MYN, IDE, and EVG

Should you be buying Sareum stock or one of its competitors? The main competitors of Sareum include Proactis (PHD), Frenkel Topping Group (FEN), Neometals (NMT), IG Design Group (IGR), Glenveagh Properties (GLV), Two Shields Investments Plc (TSI.L) (TSI), Contango (CGO), Mayan Energy (MYN), IDE Group (IDE), and Evgen Pharma (EVG). These companies are all part of the "financial services" industry.

Sareum vs. Its Competitors

Sareum (LON:SAR) and Proactis (LON:PHD) are both small-cap financial services companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations and earnings.

Proactis' return on equity of 0.00% beat Sareum's return on equity.

Company Net Margins Return on Equity Return on Assets
SareumN/A -270.25% -113.80%
Proactis N/A N/A N/A

In the previous week, Sareum had 1 more articles in the media than Proactis. MarketBeat recorded 1 mentions for Sareum and 0 mentions for Proactis. Sareum's average media sentiment score of 1.38 beat Proactis' score of 0.00 indicating that Sareum is being referred to more favorably in the media.

Company Overall Sentiment
Sareum Positive
Proactis Neutral

Proactis has higher revenue and earnings than Sareum. Sareum is trading at a lower price-to-earnings ratio than Proactis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SareumN/AN/A-£5.28M-£2.60-5.58
Proactis£48.90M0.00N/A-£20.70N/A

Summary

Proactis beats Sareum on 4 of the 7 factors compared between the two stocks.

Get Sareum News Delivered to You Automatically

Sign up to receive the latest news and ratings for SAR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SAR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SAR vs. The Competition

MetricSareumBiotechnology IndustryMedical SectorLON Exchange
Market Cap£20.02M£216.56M£6.17B£2.60B
Dividend Yield1.10%3.81%5.72%5.37%
P/E Ratio-5.583.2629.78400.34
Price / SalesN/A5,412.19495.0098,387.42
Price / Cash11.3213.1936.5527.90
Price / Book5.5690.8512.067.30
Net Income-£5.28M-£90.99M£3.32B£5.88B
7 Day Performance-10.49%-0.12%1.30%0.77%
1 Month Performance-46.20%3.37%5.93%1.01%
1 Year Performance-39.58%568.69%61.87%117.80%

Sareum Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SAR
Sareum
N/AGBX 14.50
-12.1%
N/A-29.5%£20.02MN/A-5.583,211News Coverage
Positive News
Earnings Report
High Trading Volume
PHD
Proactis
N/AN/AN/AN/A£70.69M£48.90M-3.57516
FEN
Frenkel Topping Group
N/AGBX 48.50
-1.0%
N/A+8.8%£59.60M£40.46M1,564.52307
NMT
Neometals
N/AN/AN/AN/A£57.39MN/A-1.87N/A
IGR
IG Design Group
1.8698 of 5 stars
GBX 55
-1.8%
GBX 120
+118.2%
-54.8%£52.42M£729.27M-52.583,092
GLV
Glenveagh Properties
N/AGBX 1.85
+0.3%
N/A+11.9%£9.80M£1.06B8.39502
TSI
Two Shields Investments Plc (TSI.L)
N/AN/AN/AN/A£6.15MN/A-1.053
CGO
Contango
N/AGBX 0.77
+2.7%
N/AN/A£5.84MN/A-114.932,219News Coverage
Insider Trade
Gap Up
MYN
Mayan Energy
N/AN/AN/AN/A£5.28M-£3K-0.235Gap Up
IDE
IDE Group
N/AN/AN/AN/A£3.60M£13.64M-18.13237
EVG
Evgen Pharma
N/AN/AN/AN/A£3.42MN/A-80.0010

Related Companies and Tools


This page (LON:SAR) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners